Karyopharm Therapeutics (NASDAQ:KPTI) Releases Earnings Results, Beats Estimates By $0.01 EPS
Karyopharm Therapeutics (NASDAQ:KPTI – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.01, Zacks reports. The business had revenue of $38.78 million for the quarter, compared to analyst estimates of $37.86 million. During the same period last year, […]
7 Nov 16:32 · The Cerbat Gem